Anticancer Therapies – News and Features

Children with neuroblastoma see improved outcome when immunotherapy is added to standard therapy.

The study demonstrates the effectiveness of its Nano-Cancer® therapy in the treatment of patients with recurrent glioblastoma.

Excellent clinical tolerance and high response rate support further development of inecalcitol in hormone-refractory prostate cancer.

A tiny molecule that spurs the progression of non-small-cell lung cancer could become a player in fighting the disease, researchers say.

Newly formed company looks forward to deliver specialist services to help both pharmaceutical and biotechnology companies develop new anti-cancer drugs.

The collaboration is aimed at rapidly screening the human genome for novel drug targets that selectively kill cancer cells.

Clinical research paper describes IMP321’s potency in achieving clinical benefit in 90 per cent of patients.

RNAi screening used for the first time to study Ewing’s sarcoma.

The collaboration aims to translate the abundance of new information on human genetic variation into more effective treatments for cancer.

Octapharma to use BAC’s G-CSF CaptureSelect® custom affinity ligand for the purification of recombinant human G-CSF from human cell cultures.